SCHEMBL8869647

SCHEMBL8869647

COC(=O)CNC(=O)c1ccc(NS(=O)(=O)c2ccc(Oc3cccc(C(F)(F)F)c3)cc2)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 2/20 0.50
▸ NR3C1 P04150 1/20 0.50
▸ AR P10275 1/20 0.50
▸ ESR2 Q92731 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.45
▸ MAPT P10636 7/20 0.45
▸ GAA P10253 2/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ KMT2A Q03164 5/20 0.44
▸ LMNA P02545 4/20 0.44
▸ MEN1 O00255 4/20 0.44
▸ HTT P42858 4/20 0.44
▸ NPSR1 Q6W5P4 3/20 0.44
▸ XBP1 P17861 2/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ KDR P35968 2/20 0.44
▸ POLB P06746 2/20 0.43
▸ RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869093 0.90 NR3C1 (0.52) PGRNR3C1ARESR2MAPT
SCHEMBL8868192 0.87 P4HTM (0.49) MAPTGAAMAPK1TDP1L3MBTL1
SCHEMBL8869556 0.84 POLB (0.45) ARALDH1A1KMT2ALMNAMEN1
SCHEMBL8869163 0.81 POLB (0.47) ALDH1A1MAPTMAPK1KMT2ALMNA
SCHEMBL9574758 0.79 NR3C1 (0.49) PGRNR3C1ARESR2ALDH1A1
SCHEMBL8869173 0.79 POLB (0.42) ALDH1A1KMT2ALMNAMEN1SMN1; SMN2
SCHEMBL8868444 0.77 KDR (0.49) PGRNR3C1ARESR2MAPT
SCHEMBL8869534 0.77 PGR (0.53) PGRALDH1A1TDP1KMT2ALMNA
SCHEMBL8868123 0.77 BCL2L1 (0.49) MAPTKDRMAPK14
SCHEMBL8869067 0.76 PGR (0.53) PGRLMNACACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 — — US disclosed
Send feedback